Luxna Biotech Co., Ltd.

  • EN
  • JP

Luxna Biotech Co., Ltd.

  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact
ルクサナバイオテク株式会社
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Access
  • Contact

News

  1. HOME
  2. News

Notice of exclusive license agreement for artificially modified nucleic acid technology with Takeda Pharmaceutical Company Limited

  • 2022/02/24
  • Notice
Read

Notice of Fundraising

  • 2021/12/16
  • Notice
Read

Achieved milestonesbased on the technology license agreement with Aligos Therapeutics.

  • 2021/12/10
  • Notice
Read

We will exhibit at the 3rd PharmaLab EXPO Tokyo [Pharmaceuticals] R & D exhibition booth.

  • 2021/12/06
  • Event
Read

We are selected as promising startup company by J-Startup KANSAI.

  • 2021/11/17
  • Notice
Read

Our President & CEO, Mr. Hideaki Sato, will participate in an event “Kansai Biomedical Research Group 14th Lecture” as a speaker.

  • 2021/10/15
  • Event
Read

Our President & CEO, Mr. Hideaki Sato, will participate in an event “The 15th WAKO Web Contract Seminar” as a speaker.

  • 2021/10/12
  • Event
Read

We will make a presentation at the 17th Annual Meeting of the Oligonucleotide Therapeutics Society.

  • 2021/09/22
  • Event
Read

We will be joint exhibitors with NPO Kinki Bio-industry Development Organization at Bio Japan 20201

  • 2021/09/21
  • Event
Read

Our article was published in The Discovery of Biotech Startups in Japan 2021-2022.

  • 2021/08/25
  • Interview
Read
  • 1
  • 2
  • 3
  • Next

Luxna Biotech Co., Ltd.

  • C907 9F Bldg. C, Techno-Alliance Complex, 2-8 Yamadaoka, Suita, Osaka 565-0871 JAPAN
  • TEL: +81(0)6-6170-1228
  • FAX: +81(0)6-6170-2207
  • MAIL: info@luxnabiotech.co.jp
  • About
  • Oligonucleotide Therapeutics
  • Technology
  • Business Structure
  • News
  • Open Positions
  • Contact
  • Privacy Protection Policy
  • Site Map

Copyright © 2018 Luxna Biotech Co., Ltd. All Rights Reserved.